Police are searching for a Birmingham man who suffers from Alzheimer's and has been missing since the 23rd December.
Vernol Hermon was last seen at Heartlands Hospital at 10:30pm.
The 59-year-old has a very distinctive appearance. He is described as black with very greying black long hair and a full beard. He is 5’ 8” tall and is wearing a brown coat, turquoise hospital trousers and red and white hospital slippers. He also walks with a limp.
Anyone who has seen Mr Hermon should call police urgently on 101 or the Missing People charity on 116 000.
A woman has spoken of her shock after footage filmed on a hidden camera showed her sixty-eight-year-old mother being assaulted, threatened and mocked by staff at a care home in Birmingham.
Rachael McDonald's mother Bridget suffers from a form of Alzheimer's Disease.
But her daughter noticed a change in her character and decided to hide a camera in her room. Joe Davies reports.
A warning you may find the footage in his report distressing.
Scientists at the University of Leicester hope a major breakthrough in the fight against Alzheimer's and cancer may also lead to the development of a new painkiller, using a toxin produced by a sea snail.
Scientists at the University of Leicester have made a "breakthrough" in the fight against Alzheimer's and cancer, which they have described as "the stuff of dreams."
Researchers have developed a new way to make "designer proteins" that can be used to make more effective drugs with fewer side effects.
The advance is announced by the Jamieson Research Group in the Department of Chemistry at the University of Leicester.
Their work, funded by the Engineering and Physical Sciences Research Council (EPSRC), is published in the Royal Society of Chemistry journal Organic and Biomolecular Chemistry.
Research by the Alzheimer's Society shows that 750,000 people in the UK have a form of Dementia and that more than half of those suffer with Alzheimer's disease.
Stats from 'Mapping the Dementia Gap' show thousands in Nottingham will be affected by the illness.
Number of people currently living with dementia / expected to have dementia by 2021:
- Nottingham City: 2,631 / 2,874
- Nottinghamshire: 8,625 / 11,768
In just fifteen years, it is projected that over a million people will be living with Dementia nationwide, with this figure set to soar to 1.7million by 2051.
A cure for Alzheimer's disease could be a step closer after scientists in Leicester revealed they have discovered a chemical which reverses brain degeneration in mice.
The work by the Medical Research Council based in Leicester is the first time brain damage caused by diseases like Alzheimer's and Parkinsons has been reversed.
Prof Anne Willis from the Medical Research Council explains how the treatment has restored brain cells to mice.
A charity has given a cautious welcome to the development of a 'promising' potential treatment for degenerative brain diseases, developed by a team at the University of Leicester.
An expert from the Alzheimer's Society said while the possibilities were exciting, there is still a "long way" to go before a drug suitable for use by humans will be produced.
An experimental drug shown to help treat degenerative diseases such as Alzeimer's and Parkinson's by preventing the death of brain neurons will be seen as a 'turning point' in medical history, experts claim.
The study, by the Medical Research Council's toxicology unit at the University of Leicester, saw the drug injected into the stomachs of mice to "flip" a cellular switch from 'off' to 'on', preventing the neurons from dying.
The findings have been welcomed by other experts in the field.
A landmark study by experts at the University of Leicester has raised the prospect of a pill that can treat brain diseases such as Alzheimer's by halting the death of neurons.
The research, performed on sick mice, is at a very early stage and currently the compound has "harmful" side effects, but experts say it provides the "real possibility" of developing a medicine in future.
It could be a decade or more before any such medicine suitable for human patients is developed.